PubRank

Alfredo Bardají

Author PubWeight™ 16.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am J Med 2005 2.90
2 [Management of non-ST-segment-elevation acute coronary syndromes in Spain. The DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal ESpañol) study]. Rev Esp Cardiol 2005 1.47
3 Pacemaker clinic: an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment. Europace 2011 1.38
4 [Characteristics and mortality following primary percutaneous coronary intervention for acute myocardial infarction in Spain. Results from the TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry]. Rev Esp Cardiol 2005 1.36
5 Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 2006 0.99
6 Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol 2010 0.96
7 Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. Eur J Heart Fail 2007 0.92
8 Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol (Engl Ed) 2012 0.79
9 Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients. Cardiovasc Diabetol 2013 0.79
10 Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease. Clin Biochem 2002 0.79
11 Body mass index and hospital mortality in patients with acute coronary syndrome receiving care in a university hospital. J Obes 2012 0.78
12 Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) 2012 0.78
13 Cystatin C and cardiac hypertrophy in primary hypertension. Blood Press 2010 0.77
14 [Clinical characteristics and outcome of infective endocarditis in individuals of the general population managed at a teaching hospital without cardiac surgery facilities. Study of 120 cases]. Rev Esp Cardiol 2006 0.76
15 Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol 2012 0.76
16 Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J 2012 0.76
17 [An unusual diagnostic technique of obstructive sleep apnoea syndrome]. Med Clin (Barc) 2013 0.75
18 [Intermediate coronary care units: rationale, infrastructure, equipment, and referral criteria]. Rev Esp Cardiol 2007 0.75
19 [Percutaneous intervention to a radial coronary artery graft. Initial results and follow-up]. Rev Esp Cardiol 2005 0.75
20 [Ischemic heart disease: 2006 update]. Rev Esp Cardiol 2007 0.75
21 [Update on ischemic heart disease]. Rev Esp Cardiol 2009 0.75
22 [Cardiac rupture during exercise testing]. Rev Esp Cardiol 2007 0.75
23 Identification of very low risk chest pain using clinical data in the emergency department. Int J Cardiol 2010 0.75
24 Comments on the ESC guidelines on the management of cardiovascular diseases during pregnancy. A critical vision of Spanish cardiology. Rev Esp Cardiol (Engl Ed) 2012 0.75